105 related articles for article (PubMed ID: 38947813)
21. Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by
Delang L; Yen PS; Vallet T; Vazeille M; Vignuzzi M; Failloux AB
mSphere; 2018 Aug; 3(4):. PubMed ID: 30135220
[TBL] [Abstract][Full Text] [Related]
22. Discovery of a cell-active chikungunya virus nsP2 protease inhibitor using a covalent fragment-based screening approach.
Merten EM; Sears JD; Leisner TM; Hardy PB; Ghoshal A; Hossain MA; Asressu KH; Brown PJ; Stashko MA; Herring L; Mordant AL; Webb TS; Mills CA; Barker NK; Streblow ZJ; Perveen S; Arrowsmith C; Arnold JJ; Cameron CE; Streblow DN; Moorman NJ; Heise M; Willson TM; Popov K; Pearce KH
bioRxiv; 2024 May; ():. PubMed ID: 38562906
[TBL] [Abstract][Full Text] [Related]
23. In silico identification and in vitro antiviral validation of potential inhibitors against Chikungunya virus.
Verma J; Hasan A; Sunil S; Subbarao N
J Comput Aided Mol Des; 2022 Jul; 36(7):521-536. PubMed ID: 35789450
[TBL] [Abstract][Full Text] [Related]
24. Structural insights into the inhibition of the nsP2 protease from Chikungunya virus by molecular modeling approaches.
Rabelo VW; de Palmer Paixão ICN; Abreu PA
J Mol Model; 2022 Sep; 28(10):311. PubMed ID: 36097090
[TBL] [Abstract][Full Text] [Related]
25. Host Factor Nucleophosmin 1 (NPM1/B23) Exerts Antiviral Effects against Chikungunya Virus by Its Interaction with Viral Nonstructural Protein 3.
Pradeep P; Sivakumar KC; Sreekumar E
Microbiol Spectr; 2023 Aug; 11(4):e0537122. PubMed ID: 37409962
[TBL] [Abstract][Full Text] [Related]
26. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.
Silva LA; Khomandiak S; Ashbrook AW; Weller R; Heise MT; Morrison TE; Dermody TS
J Virol; 2014 Mar; 88(5):2385-97. PubMed ID: 24371059
[TBL] [Abstract][Full Text] [Related]
27. Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.
Akhrymuk I; Lukash T; Frolov I; Frolova EI
J Virol; 2019 Feb; 93(4):. PubMed ID: 30487275
[TBL] [Abstract][Full Text] [Related]
28. Arctigenin from Arctium lappa L. inhibits chikungunya virus by affecting its entry and replication.
Shukla S; Kakade M; Cherian S; Alagarasu K; Parashar D
Phytomedicine; 2024 Jun; 128():155491. PubMed ID: 38489894
[TBL] [Abstract][Full Text] [Related]
29. Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission.
Wang YM; Lu JW; Lin CC; Chin YF; Wu TY; Lin LI; Lai ZZ; Kuo SC; Ho YJ
Antiviral Res; 2016 Nov; 135():81-90. PubMed ID: 27742486
[TBL] [Abstract][Full Text] [Related]
30. In silico and in vitro evaluation of silibinin: a promising anti-Chikungunya agent.
Dutta SK; Sengupta S; Tripathi A
In Vitro Cell Dev Biol Anim; 2022 Mar; 58(3):255-267. PubMed ID: 35381943
[TBL] [Abstract][Full Text] [Related]
31. Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo.
Rothan HA; Bahrani H; Abdulrahman AY; Mohamed Z; Teoh TC; Othman S; Rashid NN; Rahman NA; Yusof R
Antiviral Res; 2016 Mar; 127():50-6. PubMed ID: 26794398
[TBL] [Abstract][Full Text] [Related]
32. The Antiviral Alkaloid Berberine Reduces Chikungunya Virus-Induced Mitogen-Activated Protein Kinase Signaling.
Varghese FS; Thaa B; Amrun SN; Simarmata D; Rausalu K; Nyman TA; Merits A; McInerney GM; Ng LFP; Ahola T
J Virol; 2016 Nov; 90(21):9743-9757. PubMed ID: 27535052
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of novobiocin and telmisartan for anti-CHIKV activity.
Tripathi PK; Soni A; Singh Yadav SP; Kumar A; Gaurav N; Raghavendhar S; Sharma P; Sunil S; Ashish ; Jayaram B; Patel AK
Virology; 2020 Sep; 548():250-260. PubMed ID: 32791353
[TBL] [Abstract][Full Text] [Related]
34. Identification of the corticotropin-releasing factor receptor 1 antagonists as inhibitors of Chikungunya virus replication using a Gaussia luciferase-expressing subgenomic replicon.
Watanabe Y; Suzuki Y; Emi A; Murakawa T; Hishiki T; Kato F; Sakaguchi S; Wu H; Yano T; Lim CK; Takasaki T; Nakano T
Biochem Biophys Res Commun; 2022 Dec; 637():181-188. PubMed ID: 36403481
[TBL] [Abstract][Full Text] [Related]
35. Novel Analogues of the Chikungunya Virus Protease Inhibitor: Molecular Design, Synthesis, and Biological Evaluation.
Ivanova L; Rausalu K; Ošeka M; Kananovich DG; Žusinaite E; Tammiku-Taul J; Lopp M; Merits A; Karelson M
ACS Omega; 2021 Apr; 6(16):10884-10896. PubMed ID: 34056242
[TBL] [Abstract][Full Text] [Related]
36. Antiviral activity of nobiletin against chikungunya virus in vitro.
Lin SC; Chen MC; Li S; Lin CC; Wang TT
Antivir Ther; 2017; 22(8):689-697. PubMed ID: 28406093
[TBL] [Abstract][Full Text] [Related]
37. Novel Class of Chikungunya Virus Small Molecule Inhibitors That Targets the Viral Capping Machinery.
Abdelnabi R; Kovacikova K; Moesslacher J; Donckers K; Battisti V; Leyssen P; Langer T; Puerstinger G; Quérat G; Li C; Decroly E; Tas A; Marchand A; Chaltin P; Coutard B; van Hemert M; Neyts J; Delang L
Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32340991
[TBL] [Abstract][Full Text] [Related]
38. G3BP/Rin-Binding Motifs Inserted into Flexible Regions of nsP2 Support RNA Replication of Chikungunya Virus.
Wang S; Merits A
J Virol; 2022 Nov; 96(21):e0127822. PubMed ID: 36226983
[TBL] [Abstract][Full Text] [Related]
39. Beyond Members of the
Ferreira AC; Reis PA; de Freitas CS; Sacramento CQ; Villas Bôas Hoelz L; Bastos MM; Mattos M; Rocha N; Gomes de Azevedo Quintanilha I; da Silva Gouveia Pedrosa C; Rocha Quintino Souza L; Correia Loiola E; Trindade P; Rangel Vieira Y; Barbosa-Lima G; de Castro Faria Neto HC; Boechat N; Rehen SK; Brüning K; Bozza FA; Bozza PT; Souza TML
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455237
[TBL] [Abstract][Full Text] [Related]
40. CHIKV strains Brazil (wt) and Ross (lab-adapted) differ with regard to cell host range and antiviral sensitivity and show CPE in human glioblastoma cell lines U138 and U251.
Hucke FIL; Bestehorn-Willmann M; Bassetto M; Brancale A; Zanetta P; Bugert JJ
Virus Genes; 2022 Jun; 58(3):188-202. PubMed ID: 35347588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
